Alibolandi et al. used a thin film hydration technique to create EpCAM-Apt targeted DOX loaded nanocarriers for the treatment of non-small cell lung cancer (NSCLC) (Fig. 5) [79]. This evidence concerns the gene EPCAM and non-small cell lung carcinoma.